SMMTNasdaq United States
Market cap
$11.137 B
$13.96 +3.10%
Close of 7 Aug 2026
Revenue
$0.00
#3658 by revenue
Earnings
-$1.08B
Loss-making
Shares outstanding
797,749,602
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Summit Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.